Position history for RHUMBLINE ADVISERS's holdings in Catalyst Pharmaceuticals Inc
Current Value
$7.6M
Current Shares
305,520
Total Value Change
+$2.5M
Total Shares Change
-18,249
Decreased |
| 305,520 |
-2.5% |
| $7.6M |
| 0.0% |
| $23.92 |
0 |
| 2025-Q4 | Decreased | 313,414 | -5.1% | $7.3M | 0.0% | $23.29 | 0 |
| 2025-Q3 | Increased | 330,302 | +0.4% | $6.5M | 0.0% | $19.55 | 27 |
| 2025-Q2 | Increased | 329,078 | +6.0% | $7.1M | 0.0% | $21.78 | 29 |
| 2025-Q1 | Decreased | 310,568 | -0.6% | $7.5M | 0.0% | $24.69 | 0 |
| 2024-Q4 | Increased | 312,320 | +0.3% | $6.5M | 0.0% | $21.07 | 27 |
| 2024-Q3 | Decreased | 311,368 | -3.8% | $6.2M | 0.0% | $19.56 | 0 |
| 2024-Q2 | Increased | 323,769 | +3.5% | $5M | 0.0% | $15.49 | 28 |